While early GLP1 drugs focused primarily on diabetes, newer agents, such as tirzepatidebased therapies, have gained traction in treating obesity, raising efficacy expectations and increasing competitive dynamics
Enhanced cognitive function in older adults (research ongoing) [4]
By boosting vitality and supporting a healthy circulatory system, IGF-1 LR3 plays a critical role in preserving long-term heart health and protecting against cardiovascular challenges
Semaglutide is a GLP-1 receptor agonist, primarily used to treat type 2 diabetes and obesity
Most sleep research points to 18 to 20 degrees Celsius as the optimal range for sleeping
As the ER lacks glutathione reductase activity, GSSG must be exported to the cytosol by SLC33A1 to maintain redox homeostasis